These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12451218)

  • 1. MMP-9 correlates with electrophysiologic abnormalities in Guillain-Barré syndrome.
    Sharshar T; Durand MC; Lefaucheur JP; Lofaso F; Raphaël JC; Gherardi RK; Créange A
    Neurology; 2002 Nov; 59(10):1649-51. PubMed ID: 12451218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome.
    Chan YC; Punzalan-Sotelo AM; Kannan TA; Shahrizaila N; Umapathi T; Goh EJH; Fukami Y; Wilder-Smith E; Yuki N
    Muscle Nerve; 2017 Nov; 56(5):919-924. PubMed ID: 28093784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Cerebrospinal Fluid Protein Levels and Electrophysiologic Abnormalities in Guillain-Barré Syndrome.
    DiCapua DB; Lakraj AA; Nowak RJ; Robeson K; Goldstein J; Patwa H
    J Clin Neuromuscul Dis; 2015 Dec; 17(2):47-51. PubMed ID: 26583489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of repeater F-waves in the early stage of Guillain-Barré syndrome.
    Geijo-Barrientos E; González O; Pastore-Olmedo C
    J Peripher Nerv Syst; 2012 Mar; 17(1):128-31. PubMed ID: 22462674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome.
    Garssen MP; van Doorn PA; Visser GH
    J Neurol; 2006 Jul; 253(7):851-6. PubMed ID: 16845568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study.
    Durand MC; Porcher R; Orlikowski D; Aboab J; Devaux C; Clair B; Annane D; Gaillard JL; Lofaso F; Raphael JC; Sharshar T
    Lancet Neurol; 2006 Dec; 5(12):1021-8. PubMed ID: 17110282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological measurement at Erb's point during the early stage of Guillain-Barré syndrome.
    Ye Y; Zhu D; Liu L; Wang K; Huang K; Hou C
    J Clin Neurosci; 2014 May; 21(5):786-9. PubMed ID: 24412297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing electrodiagnosis for Guillain-Barré syndrome: Clues from clinical practice.
    Rajabally YA; Hiew FL
    Muscle Nerve; 2017 May; 55(5):748-751. PubMed ID: 27750406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome.
    Créange A; Sharshar T; Planchenault T; Christov C; Poron F; Raphaël JC; Gherardi RK
    Neurology; 1999 Nov; 53(8):1683-91. PubMed ID: 10563613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome.
    Durand MC; Prigent H; Sivadon-Tardy V; Orlikowski D; Caudie C; Devaux C; Clair B; Gaillard JL; Lofaso F; Raphael JC; Sharshar T
    Neurology; 2005 Nov; 65(10):1646-9. PubMed ID: 16301497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cauda equina conduction time in Guillain-Barré syndrome.
    Matsumoto H; Hanajima R; Terao Y; Hashida H; Ugawa Y
    J Neurol Sci; 2015 Apr; 351(1-2):187-190. PubMed ID: 25770878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of "A" Waves in Patients With Guillain Barre Syndrome.
    Badry R
    J Clin Neurophysiol; 2019 Sep; 36(5):385-388. PubMed ID: 31033653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome.
    Bolton CF
    Neurology; 2006 Jun; 66(12):1961; author reply 1961. PubMed ID: 16801681
    [No Abstract]   [Full Text] [Related]  

  • 14. Paraparetic Guillain-Barré syndrome: Nondemyelinating reversible conduction failure restricted to the lower limbs.
    Kimachi T; Yuki N; Kokubun N; Yamaguchi S; Wakerley BR
    Muscle Nerve; 2017 Feb; 55(2):281-285. PubMed ID: 27397635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain-Barré syndrome.
    Shahrizaila N; Goh KJ; Abdullah S; Kuppusamy R; Yuki N
    Clin Neurophysiol; 2013 Jul; 124(7):1456-9. PubMed ID: 23395599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies.
    Kuwabara S; Ogawara K; Mizobuchi K; Koga M; Mori M; Hattori T; Yuki N
    J Neurol Neurosurg Psychiatry; 2000 Feb; 68(2):191-5. PubMed ID: 10644786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome.
    Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS
    J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barre syndrome in children and adolescents--a retrospective analysis.
    Ramachandran R; Kuruvilla A
    J Indian Med Assoc; 2004 Sep; 102(9):480-2, 484, 486. PubMed ID: 15887834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand?
    Uncini A; Kuwabara S
    Clin Neurophysiol; 2018 Dec; 129(12):2586-2593. PubMed ID: 30419502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological findings in early Guillain-Barré syndrome.
    Baraba R; Sruk A; Sragalj L; Butković-Soldo S; Bielen I
    Acta Clin Croat; 2011 Jun; 50(2):201-7. PubMed ID: 22263383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.